
Scholar Rock’s Phase 3 Trial for SMA Shows Positive Results with Apitegromab
Quick Summary Therapy: Apitegromab, a muscle-targeted monoclonal antibody Trial Outcome: Significant improvements in motor function for non-ambulatory SMA patients Regulatory Plans: Scholar Rock intends to